Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Aytu Biopharma (AYTU) Non Operating Income: 2010-2025

Historic Non Operating Income for Aytu Biopharma (AYTU) over the last 15 years, with Sep 2025 value amounting to $201,000.

  • Aytu Biopharma's Non Operating Income fell 62.92% to $201,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$853,000, marking a year-over-year decrease of 203.02%. This contributed to the annual value of -$512,000 for FY2025, which is 158.85% down from last year.
  • Aytu Biopharma's Non Operating Income amounted to $201,000 in Q3 2025, which was up 116.34% from -$1.2 million recorded in Q2 2025.
  • In the past 5 years, Aytu Biopharma's Non Operating Income registered a high of $3.7 million during Q2 2023, and its lowest value of -$1.2 million during Q2 2025.
  • For the 3-year period, Aytu Biopharma's Non Operating Income averaged around $277,727, with its median value being $120,000 (2024).
  • In the last 5 years, Aytu Biopharma's Non Operating Income skyrocketed by 527.41% in 2022 and then slumped by 1,125.00% in 2025.
  • Aytu Biopharma's Non Operating Income (Quarterly) stood at -$257,000 in 2021, then slumped by 377.82% to -$1.2 million in 2022, then spiked by 107.82% to $96,000 in 2023, then surged by 45.83% to $140,000 in 2024, then slumped by 62.92% to $201,000 in 2025.
  • Its last three reported values are $201,000 in Q3 2025, -$1.2 million for Q2 2025, and $36,000 during Q1 2025.